Trial intelligence / Profile preview

Safety and Efficacy of ABLC vs Amphotericin B in AIDS-associated Cryptococcal Meningitis

NCT00002019Phase 2Completed

Sponsor
Liposome Company
Modality
Nanoparticles
Countries
1
01

Overview

A Phase 2 trial of amphotericin B lipid complex in cryptococcal meningitis, sponsored by Liposome Company. Status: completed.

02

Drugs

amphotericin B lipid complex
03

Conditions

cryptococcal meningitis

Beyond the preview

Go deeper on NCT00002019.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00002019.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call